Filling the need for trusted information on national health issues…

Drug Resistance

  • Your Selections:

Refine Results

date

Tags

At WHA, DNDi, WHO Launch Antibiotic R&D Initiative, Attendees Discuss Outbreak Preparedness

Intellectual Property Watch: Initiative To Find New Antibiotics Being Launched At WHA “A new initiative seeking to develop new antibiotic treatments [was] launched [Tuesday] at the annual World Health Assembly. The Global Antibiotic Research and Development (GARD) is a partnership between the World Health Organization and the Drugs for Neglected…

Political Leadership Needed To Address Drug Resistance, The Economist Reports

The Economist: When the drugs don’t work “…Resistance to antimicrobial medicines, such as antibiotics and antimalarials, is caused by the survival of the fittest. Unfortunately, fit microbes mean unfit human beings. … Combining policies to accomplish many things at once demands political leadership, but recent global campaigns against HIV/AIDS and…

Drug Companies Should Be Incentivized To Develop New Antibiotics

Financial Times: Pull together to prevent a superbug apocalypse Editorial Board “…Although [the final report of the Review on Antimicrobial Resistance] is full of excellent proposals, early comments have targeted one of its most eye-catching and least well-thought-out ideas: a ‘play or pay’ scheme. Pharmaceutical companies would either pay a…

WHO’s New Treatment, Testing Recommendations For Drug-Resistant TB ‘Offer Hope’

Huffington Post: A Turning Point in the Battle Against Drug-Resistant Tuberculosis Ariel Pablos-Mendez, assistant administrator for global health and child and maternal survival coordinator at USAID, and Mario Raviglione, director of the WHO Global TB Program “…[T]wo new recommendations [on multidrug-resistant tuberculosis (MDR-TB)] from WHO offer hope. The first, on…

New WHO Guidelines Recommend Shorter Treatment Regimen For Drug-Resistant TB

BBC News: Shorter treatment ‘will help tackle’ drug-resistant TB “New international guidelines aim to halve the cost and time for treating multi-drug resistant tuberculosis (MDR-TB). The advice from the World Health Organization (WHO) should reduce treatment to around nine months…” (Dreaper, 5/12). The Guardian: WHO recommends shorter drug regimen for…

Nations Ponder Financial Incentives To Spur New Antibiotic Research, Development

The Lancet: Countries mull over incentives for developing antibiotics “The prospect of slipping into a deadly, post-antibiotic era is prompting countries across the world to work out when and what they are willing to pay drug companies to develop desperately needed antibiotics. Governments have commissioned academics, economists, business analysts, and…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.